Cite
Bianca: Phase II, single-arm, global trial to determine efficacy and safety of tisagenlecleucel in pediatric/young adult (YA) patients (Pts) with relapsed/refractory B-cell non-Hodgkin lymphoma (R/R B-NHL)
MLA
Lida Bubuteishvili-Pacaud, et al. “Bianca: Phase II, Single-Arm, Global Trial to Determine Efficacy and Safety of Tisagenlecleucel in Pediatric/Young Adult (YA) Patients (Pts) with Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (R/R B-NHL).” Journal of Clinical Oncology, vol. 38, May 2020, p. e22504. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........045d6cd82373ec2ef3cb69012a1b1d91&authtype=sso&custid=ns315887.
APA
Lida Bubuteishvili-Pacaud, Simon Newsome, Berta González Martínez, Joerg Krueger, Andishe Attarbaschi, Theodore W. Laetsch, Jaclyn Davis, Franco Locatelli, Véronique Minard, Shannon L. Maude, Birgit Burkhardt, Cristina Diaz de Heredia Rubio, Jochen Buechner, & Rakesh Awasthi. (2020). Bianca: Phase II, single-arm, global trial to determine efficacy and safety of tisagenlecleucel in pediatric/young adult (YA) patients (Pts) with relapsed/refractory B-cell non-Hodgkin lymphoma (R/R B-NHL). Journal of Clinical Oncology, 38, e22504.
Chicago
Lida Bubuteishvili-Pacaud, Simon Newsome, Berta González Martínez, Joerg Krueger, Andishe Attarbaschi, Theodore W. Laetsch, Jaclyn Davis, et al. 2020. “Bianca: Phase II, Single-Arm, Global Trial to Determine Efficacy and Safety of Tisagenlecleucel in Pediatric/Young Adult (YA) Patients (Pts) with Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (R/R B-NHL).” Journal of Clinical Oncology 38 (May): e22504. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........045d6cd82373ec2ef3cb69012a1b1d91&authtype=sso&custid=ns315887.